CORTIFOAM Drug Patent Profile
When do Cortifoam patents expire, and when can generic versions of Cortifoam launch?
Cortifoam is a drug marketed by Viatris and is included in one NDA.
The generic ingredient in CORTIFOAM is hydrocortisone acetate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CORTIFOAM?
- What are the global sales for CORTIFOAM?
- What is Average Wholesale Price for CORTIFOAM?
Summary for CORTIFOAM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,149 |
| Drug Prices: | Drug price information for CORTIFOAM |
| What excipients (inactive ingredients) are in CORTIFOAM? | CORTIFOAM excipients list |
| DailyMed Link: | CORTIFOAM at DailyMed |
Recent Clinical Trials for CORTIFOAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| M.D. Anderson Cancer Center | Phase 3 |
| National Cancer Institute (NCI) | Phase 3 |
Pharmacology for CORTIFOAM
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for CORTIFOAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viatris | CORTIFOAM | hydrocortisone acetate | AEROSOL, METERED;RECTAL | 017351-001 | Feb 10, 1982 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
